GlassScriptPhysician profile
Gabriel Petty
NPI 1447485214
$5,483.50
in general payments reported to CMS, 2019-2025
31 companies · $1,827 in 2025
The $1,827 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $871 · 2023: $815 · 2024: $1,533 · 2025: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,161 · Travel and Lodging: $14.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,160.70 |
| Travel and Lodging | $14.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $638.41 | 2022-2024 | Kyphon Express II Kyphopak Tray, Signia, Intellis Adaptivestim |
| Amgen INC. | $619.74 | 2021-2024 | Otezla, Repatha |
| Abbott Laboratories | $589.87 | 2022-2025 | Proclaim |
| Novo Nordisk INC | $478.15 | 2023-2025 | Ozempic, Wegovy |
| Scpharmaceuticals INC. | $276.25 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $257.05 | 2024-2025 | Voquezna |
| Nevro Corp. | $243.09 | 2024 | Senza |
| Astrazeneca Pharmaceuticals LP | $228.20 | 2022-2023 | Fasenra |
| Si-Bone, INC. | $147.60 | 2023 | |
| Zimvie INC. | $144.41 | 2024 | |
| Bolton Medical INC | $135.36 | 2025 | Metacross Otw, Relay Thoracic Stent-Graft With Plus Delivery System |
| Sanofi US Services INC. | $132.10 | 2025 | |
| Alkermes, INC. | $124.99 | 2025 | Vivitrol |
| Biohaven Pharmaceutical Holding Company LTD. | $123.59 | 2022 | |
| Genzyme Corporation | $122.80 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.94 | 2025 | Xifaxan |
| Lilly USA, LLC | $116.15 | 2025 | Zepbound |
| Alnylam Pharmaceuticals INC. | $115.04 | 2024 | Onpattro |
| Teva Pharmaceuticals USA, INC. | $112.34 | 2025 | Austedo Xr |
| Antares Pharma, INC. | $105.09 | 2023 | Xyosted, Tlando |
| Corcept Therapeutics | $103.88 | 2023 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $102.07 | 2022 | |
| Bioventus LLC | $94.30 | 2021 | |
| Abbvie INC. | $84.43 | 2021 | |
| Genentech USA, INC. | $79.88 | 2021 | |
| Inspire Medical Systems, INC. | $52.49 | 2025 | Inspire |
| Depuy Synthes Sales INC. | $42.48 | 2021-2024 | Truespan Orthocord |
| Boston Scientific Corporation | $31.75 | 2021 | |
| Zimmer Biomet Holdings, INC. | $30.60 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Organogenesis INC. | $17.43 | 2025 | Via Matrix |
| Curonix LLC | $16.02 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Petty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.